Principal Financial Group
HRMY icon

Principal Financial Group’s Harmony Biosciences HRMY Stock Holding History

Principal Financial Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.66M Buy
265,242
+6,558
+3% +$207K ﹤0.01% 1422
2026
Q1 		$7.25M Buy
258,684
+6,109
+2% +$200K ﹤0.01% 1487
2025
Q4 		$9.45M Buy
252,575
+21,646
+9% +$712K ﹤0.01% 1342
2025
Q3 		$6.36M Buy
230,929
+319
+0.1% +$11K ﹤0.01% 1499
2025
Q2 		$7.29M Buy
230,610
+17,194
+8% +$553K ﹤0.01% 1408
2025
Q1 		$7.08M Buy
213,416
+4,753
+2% +$170K ﹤0.01% 1425
2024
Q4 		$7.18M Buy
208,663
+46,194
+28% +$1.59M ﹤0.01% 1450
2024
Q3 		$6.5M Sell
162,469
-19,654
-11% -$690K ﹤0.01% 1473
2024
Q2 		$5.49M Sell
182,123
-9,927
-5% -$298K ﹤0.01% 1527
2024
Q1 		$6.45M Sell
192,050
-5,994
-3% -$192K ﹤0.01% 1489
2023
Q4 		$6.4M Sell
198,044
-1,706
-0.9% -$47.6K ﹤0.01% 1477
2023
Q3 		$6.55M Buy
199,750
+16,260
+9% +$564K ﹤0.01% 1427
2023
Q2 		$6.46M Sell
183,490
-3,173
-2% -$110K ﹤0.01% 1437
2023
Q1 		$6.09M Sell
186,663
-5,691
-3% -$259K ﹤0.01% 1468
2022
Q4 		$10.6M Sell
192,354
-5,622
-3% -$309K 0.01% 1213
2022
Q3 		$8.77M Buy
197,976
+7,145
+4% +$349K 0.01% 1259
2022
Q2 		$9.31M Sell
190,831
-4,907
-3% -$221K 0.01% 1298
2022
Q1 		$9.52M Buy
195,738
+37,181
+23% +$1.52M 0.01% 1403
2021
Q4 		$6.76M Buy
+158,557
New +$6.32M ﹤0.01% 1562

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Principal Financial Group's HRMY Position: Q2 2026 in Review

Principal Financial Group increased its Harmony Biosciences (HRMY) stake by 2.5% in Q2 2026, buying an estimated $207K and bringing the position to 265,242 shares worth $9.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

Principal Financial Group first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $10.6M in Q4 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Principal Financial Group held 265,242 shares of Harmony Biosciences worth $9.66M as of Q2 2026.
  • Principal Financial Group bought 6,558 Harmony Biosciences shares in Q2 2026, an estimated $207K.
  • Harmony Biosciences made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1422 holding.
  • Principal Financial Group first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Principal Financial Group's Harmony Biosciences position peaked at $10.6M in Q4 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.